Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
All figures in $USD unless otherwise noted. TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- Firm Capital Apartment Real Estate Investment Trust (“the “Trust”), (TSXV: FCA.U), (TSXV: FCA.UN) is pleased...
-
SINGAPORE, April 07, 2026 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization...
-
The case alleges that Driven Brands misled investors as to its financial condition and the effectiveness of its internal controls over financial reporting.
-
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Jefferies Financial Group Inc. (“Jefferies” or the “Company”) (NYSE: JEF). Such...
-
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vertical Aerospace Ltd. (“Vertical Aerospace” or the “Company”) (NYSE: EVTL). Such...
-
Net loss on a GAAP basis was $2.8 million for the current quarter compared with a net loss of $7.1 million for the prior year quarter, each period inclusive of various non-cash charges, representing a...
-
Successful transformation to global biotech platform with two mid-stage potential best-in-class/first-in-class programs, givastomig and VIS-101, with compelling proof-of-concept dataGivastomig, a...
-
ENGLEWOOD, Colo., April 07, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release first quarter 2026 earnings results on Thursday, May 7, 2026 after market...
-
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Capital Link is pleased to release the Q1 2026 edition of its Quarterly Shipping Insights—a carefully curated collection of original articles based on...
-
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO). Such...